| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14760584.2016.1170598 |
| P698 | PubMed publication ID | 27010618 |
| P2093 | author name string | Robert J Hogan | |
| Eric R Lafontaine | |||
| Sophie A Aschenbroich | |||
| P2860 | cites work | Melioidosis: epidemiology, pathophysiology, and management | Q24522461 |
| The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice | Q24635244 | ||
| Pneumonia and septicemia caused by Burkholderia thailandensis in the United States | Q24672787 | ||
| New approaches to vaccine adjuvants: inhibiting the inhibitor | Q25256562 | ||
| An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells | Q25256583 | ||
| Development of Burkholderia mallei and pseudomallei vaccines | Q26861271 | ||
| Consensus on the development of vaccines against naturally acquired melioidosis | Q26864912 | ||
| Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development | Q27304432 | ||
| Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei | Q27305217 | ||
| Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis | Q27305350 | ||
| Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes | Q27305733 | ||
| Interleukin-1 receptor antagonist: role in biology | Q28271409 | ||
| Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei | Q28299584 | ||
| The Identification and Differentiation between Burkholderia mallei and Burkholderia pseudomallei Using One Gene Pyrosequencing | Q28828549 | ||
| Negative regulation of toll-like receptor-mediated immune responses | Q29619019 | ||
| Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders | Q30279061 | ||
| Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei | Q33372589 | ||
| A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis | Q33601907 | ||
| Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate | Q33661479 | ||
| Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity | Q33756790 | ||
| Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection | Q33826261 | ||
| Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery. | Q33965527 | ||
| Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents | Q48076538 | ||
| Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice. | Q53654388 | ||
| Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders | Q57942331 | ||
| Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. | Q34034124 | ||
| Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis | Q34058969 | ||
| Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates | Q34081215 | ||
| Protective antigens against glanders identified by expression library immunization | Q34085654 | ||
| Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice | Q34121068 | ||
| A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis | Q34130336 | ||
| CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice | Q34491695 | ||
| A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei | Q34491754 | ||
| Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling | Q34575866 | ||
| The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei | Q34740016 | ||
| Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions. | Q34783879 | ||
| Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine | Q35007523 | ||
| Russian vaccines against especially dangerous bacterial pathogens. | Q35050833 | ||
| Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide | Q35058621 | ||
| A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei | Q35088366 | ||
| Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis | Q35129390 | ||
| Mining host-pathogen protein interactions to characterize Burkholderia mallei infectivity mechanisms. | Q35147602 | ||
| Strategies for Intracellular Survival of Burkholderia pseudomallei. | Q35173801 | ||
| Diversity and significance of Burkholderia species occupying diverse ecological niches. | Q35200150 | ||
| Development of vaccines against burkholderia pseudomallei | Q35234118 | ||
| Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway | Q35328947 | ||
| A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection | Q35375333 | ||
| Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis | Q35689501 | ||
| Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region | Q35805361 | ||
| T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients | Q35818580 | ||
| Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models. | Q35874189 | ||
| The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model. | Q35913365 | ||
| High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei | Q35913459 | ||
| SOCS, Inflammation, and Autoimmunity | Q35927538 | ||
| Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice | Q35940681 | ||
| Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival | Q35947308 | ||
| Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis | Q35949725 | ||
| Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice | Q36159605 | ||
| Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity | Q36163108 | ||
| Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. | Q36445263 | ||
| Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity | Q36517179 | ||
| Burkholderia vaccines: are we moving forward? | Q36587103 | ||
| DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response | Q36657472 | ||
| Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule. | Q36970284 | ||
| Protection from pneumonic infection with burkholderia species by inhalational immunotherapy | Q37145069 | ||
| Glanders | Q37246291 | ||
| Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. | Q37336008 | ||
| Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis | Q37374659 | ||
| Monitoring Therapeutic Treatments against Burkholderia Infections Using Imaging Techniques | Q37384332 | ||
| Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge. | Q37417238 | ||
| Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. | Q37582820 | ||
| Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection. | Q37623675 | ||
| Progress toward development of vaccines against melioidosis: A review | Q37781595 | ||
| Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures | Q38013157 | ||
| Dissecting negative regulation of Toll-like receptor signaling | Q38020637 | ||
| CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). | Q38288131 | ||
| Inhalation of Burkholderia thailandensis results in lethal necrotizing pneumonia in mice: a surrogate model for pneumonic melioidosis | Q38600939 | ||
| A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins | Q39045739 | ||
| Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge | Q39128843 | ||
| Involvement of signal regulatory protein α, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages | Q39276546 | ||
| Burkholderia pseudomallei-induced expression of suppressor of cytokine signaling 3 and cytokine-inducible src homology 2-containing protein in mouse macrophages: a possible mechanism for suppression of the response to gamma interferon stimulation | Q39392924 | ||
| Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing | Q39544582 | ||
| Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification | Q39592751 | ||
| Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM. | Q39723299 | ||
| Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages | Q39755072 | ||
| A disruption of ctpA encoding carboxy-terminal protease attenuates Burkholderia mallei and induces partial protection in CD1 mice. | Q39963333 | ||
| Expression of suppressor of cytokine signaling 3 (SOCS3) and cytokine-inducible Src homology 2-containing protein (CIS) induced in Burkholderia pseudomallei--infected mouse macrophages requires bacterial internalization | Q40180691 | ||
| Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin | Q40388090 | ||
| Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin | Q40836587 | ||
| Burkholderia mallei and Burkholderia pseudomallei stimulate differential inflammatory responses from human alveolar type II cells (ATII) and macrophages | Q41996760 | ||
| Sterile-α- and armadillo motif-containing protein inhibits the TRIF-dependent downregulation of signal regulatory protein α to interfere with intracellular bacterial elimination in Burkholderia pseudomallei-infected mouse macrophages | Q42572720 | ||
| Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis | Q42908999 | ||
| Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. | Q43218668 | ||
| Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. | Q43254880 | ||
| Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle | Q43838811 | ||
| Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). | Q44057312 | ||
| Gene-expression profiles in murine melioidosis | Q46693862 | ||
| P433 | issue | 9 | |
| P921 | main subject | melioidosis | Q963944 |
| P304 | page(s) | 1163-1181 | |
| P577 | publication date | 2016-03-24 | |
| P1433 | published in | Expert Review of Vaccines | Q15756339 |
| P1476 | title | Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches | |
| P478 | volume | 15 |
| Q46242885 | A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates. |
| Q60922208 | Antibodies Are Major Drivers of Protection against Lethal Aerosol Infection with Highly Pathogenic spp |
| Q38784773 | Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei |
| Q92233675 | Cyclopropanol Warhead in Malleicyprol Confers Virulence of Human- and Animal-Pathogenic Burkholderia Species |
| Q53717112 | DNA vaccination resurfaces in the struggle against melioidosis. |
| Q90569305 | Emerging role of biologics for the treatment of melioidosis and glanders |
| Q39126286 | Innate immune response to Burkholderia mallei |
| Q93379611 | MarR Family Transcription Factors from Burkholderia Species: Hidden Clues to Control of Virulence-Associated Genes |
| Q57094969 | Melioidosis |
| Q61699558 | Melioidosis |
| Q99609310 | Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei |
| Q40286028 | Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application. |
| Q38839466 | The art of persistence-the secrets to Burkholderia chronic infections. |
| Q94568361 | The autotransporter protein BatA is a protective antigen against lethal aerosol infection with and |
Search more.